CADTH | Search

Current Filters

Showing 3571 - 3579 results of 3579

Aclidinium bromide (Tudorza Genuair) (Last Updated: Aug 21, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Tudorza Genuair
Manufacturer:
Almirall Canada Ltd.
Submission Type:
Initial
Indications:

Chronic Obstructive Pulmonary Disease (COPD)

Guanfacine hydrochloride (Intuniv XR) (Last Updated: Aug 27, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Intuniv XR
Manufacturer:
Shire Canada Inc.
Submission Type:
Initial
Indications:

Attention-deficit/hyperactivity disorder (ADHD)

OnabotulinumtoxinA (Botox) (Last Updated: Aug 15, 2013)

Request for Resubmission: Eligible (Decision Date: June 5, 2018)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Botox
Manufacturer:
Allergan Inc.
Submission Type:
Initial
Indications:

Migraine, chronic

Eplerenone (Inspra) (Last Updated: Jul 12, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Inspra
Manufacturer:
Pfizer Canada Inc.
Submission Type:
Initial
Indications:

Heart failure, NYHA class II

Golimumab (Simponi) (Last Updated: Jul 12, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Simponi
Manufacturer:
Janssen Inc.
Submission Type:
Initial
Indications:

Ulcerative colitis

Tocilizumab (Actemra) (Last Updated: Jul 29, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Actemra
Manufacturer:
Hoffmann-La Roche Limited
Submission Type:
Initial
Indications:

Polyarticular juvenile idiopathic arthritis

Saxagliptin + metformin (Komboglyze) (Last Updated: Jun 6, 2013)

Project Line:
Reimbursement Review
Project Status:
Withdrawn
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Komboglyze
Manufacturer:
Bristol-Myers Squibb / AstraZeneca Canada Inc.
Submission Type:
Initial
Indications:

Diabetes Mellitus, Type 2

Ocriplasmin (Jetrea) (Last Updated: Jun 6, 2013)

Project Line:
Reimbursement Review
Project Status:
Complete
Contains:
Brand Name Manufacturer Submission Type Indications

Brand Name:
Jetrea
Manufacturer:
Alcon Canada Inc.
Submission Type:
Initial
Indications:

Vitreomacular adhesion

Early Intervention Programs for Adolescents With Eating Disorders (Last Updated: Mar 21, 2023)

Eating disorders are serious but treatable conditions with the highest mortality rates among mental health disorders. They account for approximately 10% to 15% of mental illness deaths. According to a...

Project Line:
Health Technology Review
Project Status:
Active
Download results as CSV